Swissmedic
REGULATORY UPDATE
Additional information on the Guidance document “Import of a human medicinal product according to Art. 14 para. 2 and 3 TPA (parallel import)”
Published: 11/2/2026Detected: 11/2/2026
Summary preview
Clarifies additional information to support the Swiss parallel import pathway under TPA Art. 14(2) and (3), potentially refining expectations for how parallel imports are documented and assessed.
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free account#parallel import
#TPA
#Swissmedic
#import of medicinal product
#regulatory dossier
Official Source Document Source Verified
Access the original document directly from SWISSMEDIC.
More from Swissmedic
- Modification of the “Form DMF”11/1/2026
- Update to the forms New authorisation of human medicinal products and Variations and extensions HAM11/1/2026
- New information on the introduction of eCTD v4.010/26/2026
- GMP compliance by foreign manufacturers10/9/2026
- Changes to the Guidance document “Import of a human medicinal product according to Art. 14 para. 2 and 3 TPA (parallel import)”10/1/2026